ECSP982536A - USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K) - Google Patents
USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K)Info
- Publication number
- ECSP982536A ECSP982536A ECSP982536A ECSP982536A EC SP982536 A ECSP982536 A EC SP982536A EC SP982536 A ECSP982536 A EC SP982536A EC SP982536 A ECSP982536 A EC SP982536A
- Authority
- EC
- Ecuador
- Prior art keywords
- protein transferase
- ino750k
- farnesilo
- inhibition
- case
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000004357 Transferases Human genes 0.000 title abstract 2
- 108090000992 Transferases Proteins 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 230000011712 cell development Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe nuevos compuestos de fórmula: (gráfico), también se describe un método para inhibir la función de la transferasa de la proteína al farnesilo y para inhibir por lo tanto el desarrollo normal de células. El método comprende administrar un compuesto de la precedente fórmula a un sistema biológico. En particular, el método inhibe el desarrollo normal de células en un mamífero tal como un ser humano.Novel compounds of formula are described: (graph), a method of inhibiting the function of protein transferase to farnesyl is also described, and thus inhibiting normal cell development. The method comprises administering a compound of the preceding formula to a biological system. In particular, the method inhibits normal cell development in a mammal such as a human.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982536 ECSP982536A (en) | 1998-06-16 | 1998-06-16 | USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982536 ECSP982536A (en) | 1998-06-16 | 1998-06-16 | USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982536A true ECSP982536A (en) | 1999-04-21 |
Family
ID=42043456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982536 ECSP982536A (en) | 1998-06-16 | 1998-06-16 | USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982536A (en) |
-
1998
- 1998-06-16 EC ECSP982536 patent/ECSP982536A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69628556D1 (en) | TRICYCLIC COMPOUNDS AS INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | |
| CO5251404A1 (en) | AZALIDA ANTIBIOTIC COMPOUNDS | |
| DE60030741D1 (en) | CHINAZOLINE COMPOUNDS AS A REMEDY | |
| ATE148130T1 (en) | TYPE IV DIPEPTIDYL AMINOOPEPTIDASE INHIBITORS | |
| DE69612003D1 (en) | SUBSTITUTED BENZOLACTATE COMPOUNDS AS SUBSTANCE P-ANTAGONISTS | |
| BR0200782A (en) | Compounds for the treatment of ischemia | |
| ZA981936B (en) | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. | |
| BR9807876A (en) | Heterocyclic compounds and their use for inhibition of beta-amyloid peptide | |
| PT939627E (en) | PENTAFLUOROBENZENOSULFONAMIDAS AND ANALOGOS | |
| AR024138A1 (en) | INHIBITORS OF THE CELL PROLIFERATION | |
| BR0013666A (en) | "alpha" -hydroxy acids substituted for caspase inhibitors and their use | |
| TR199900310T2 (en) | Thrombin inhibitors | |
| CO5261493A1 (en) | PROCEDURE AND COMPOUNDS FOR THE INHIBITION OF MRP1 | |
| BR0317284A (en) | Mitogen-Activated Protein Kinase-2 Aminocyanopyridine Inhibitors | |
| MY143570A (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| MXPA03004209A (en) | Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans cell migration. | |
| ID17291A (en) | INHIBITION OF METALLOPROTEASE MATRIX BY SUBSTITUTED OXYBOUTIRATE ACID | |
| ES2156633T3 (en) | DERIVATIVES OF TIAZOLIDINE-4-CARBOXYL ACID AS CITOPROTECTING AGENTS. | |
| NO985679D0 (en) | Dihydrobenzopyran and related compounds useful as anti-inflammatory agents | |
| BR0308601A (en) | plasma carboxypeptidase b inhibitors | |
| TR199900153T2 (en) | Substituted bisindolylmaleimides to prevent cell proliferation. | |
| ECSP982536A (en) | USEFUL COMPOUNDS FOR THE INHIBITION OF PROTEIN TRANSFERASE TO FARNESILO (CASE INO750K) | |
| ATE299140T1 (en) | FARNESYL PROTEIN TRANSFERASE INHIBITORS | |
| AR031126A1 (en) | AMINO ACIDS (OXO) INHIBITING ACETICS OF PROTEIN TIROSINA FOSFATASA | |
| CA2293358A1 (en) | Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |